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ABSTRACT
Purpose: More research into the psychosocial aspects
of diabetes is needed so that the health and quality of
life of people with the condition can be improved. To
fill this gap, we conducted the second Diabetes MILES
—Australia study (MILES-2), a survey focused on
psychological, behavioural and social aspects of
diabetes. The aim of the MILES-2 study was to provide
a (1) longitudinal follow-up of the original MILES 2011
study cohort; (2) cross-sectional assessment of a new
cohort.
Participants: Eligible participants were English-
speaking Australians with type 1 or type 2 diabetes,
aged 18–75 years. Longitudinal cohort participants
were mailed/emailed study invitations directly by
researchers. Random sampling (stratified by diabetes
type, insulin use, state) of the National Diabetes
Services Scheme (NDSS) database and nationwide
advertisements were used to recruit new cohort
participants. The final sample included N=2342
eligible respondents (longitudinal cohort: n=504;
2015 new cohort: n=1838); 54% had type 2
diabetes.
Findings to date: Survey respondents were from
an advantaged socioeconomic background compared
to the general population. Respondents with type 1
diabetes were over-represented in the new cohort
(45%) relative to the planned stratification (40% type
1 diabetes, 60% type 2 diabetes). Respondents with
insulin-treated type 2 diabetes were under-
represented in the new cohort relative to the
stratified sampling (42% invited vs 50% response).
Participants who completed both the 2011 and 2015
surveys were more likely than those completing the
2011 survey only to have type 1 diabetes, report a
higher education and annual income, and live in
metropolitan areas. Participant feedback indicated
that the survey was perceived as relevant and
valuable.
Future plans: The depth and breadth of the data
available in this large sample will highlight unmet
needs and priority areas for future investigation
and, crucially, will inform policy, programme
and intervention development and evaluation in
Australia.
INTRODUCTION
Diabetes is one of the most challenging
public health issues faced today. The number
of people with diabetes has doubled globally
in recent decades,1 and it is predicted that
by 2040, 642 million people will have dia-
betes.2 Australia is no exception to the global
trend, where diabetes is the fastest growing
chronic condition, and type 2 diabetes
expected to be the largest health burden by
2023.3 While the majority of Australians with
diabetes have type 2 diabetes, the prevalence
of both type 1 and type 2 diabetes is
increasing.4
There have been many developments in
recent years to improve the management of
diabetes: medications (eg, insulin analogues,
GLP-1 agonists and sodium-glucose cotran-
sporter 2 (SGLT2) inhibitors), technologies
(eg, wearable glucose monitoring devices,
‘artiﬁcial pancreas’, smartphone apps to
Strengths and limitations of this study
▪ Key strengths of MILES-2 are the breadth and
depth of quantitative data and the large,
population-based sample size, which provides
sufficient power for various statistical analyses.
▪ The emerging longitudinal data set enables
investigation of predictors and consequences of
psychological distress and suboptimal self-
management, for the first time, in a non-clinical,
population-based sample.
▪ The response rates for both the longitudinal
(26%) and the new cohorts (8%) in the MILES-2
survey were low.
▪ In the longitudinal cohort, substantial attrition
was evident between the 2011 and 2015 surveys.
▪ Participants were from a relatively advantaged
background, which may result in the under-
estimation of social and emotional problems,
and problems of healthcare access.
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support self-management), education (eg, structured
group training programmes, online self-directed inter-
ventions) and healthcare access (eg, multidisciplinary
single-site care, subsidies for devices and consumables).
Despite this, many people with diabetes still experience
the condition as burdensome and unrelenting.5
Achieving recommended treatment targets remains a
signiﬁcant challenge for many people with diabetes.
Data from the National Health and Nutrition
Examination Surveys (NHANES) in the USA indicate
that <20% of people with diabetes have in-target gly-
cated haemoglobin, blood pressure and cholesterol,6
and that this proportion of people meeting the recom-
mended treatment goals has improved only slightly over
time.7 Australian data from 2013 to 2014 indicate that
<50% of people with diabetes in primary care are
meeting glycaemic targets, and only 20% are meeting all
glycaemic and cardiovascular outcome targets.8 In addi-
tion, severe hypoglycaemia remains all too common,
with around 20% of adults with diabetes reporting
severe hypoglycaemia in the past 3–6 months.9–11
Systematic reviews demonstrate that psychological pro-
blems are prevalent,12–16 including clinically signiﬁcant
depressive symptoms (reported by 8–29% of adults with
diabetes; though concerns about over-diagnosis have
been raised17),12 13 18 19 anxiety (among 7–14%)14 19 20
and diabetes distress (among 18–39%).19 21 22
Impaired psychological well-being is associated with
poorer quality of life, as well as with less optimal self-care
behaviours, hyperglycaemia, a higher risk of developing
microvascular and macrovascular complications of dia-
betes, and higher mortality rates.23–26 This suggests that
more research into the behavioural and psychological
aspects of diabetes is needed to generate further insights
into how both health and quality of life outcomes can
be improved. Indeed, there have recently been calls for
the prioritisation of research that seeks to understand
and address the psychological well-being of people with
diabetes.27 28
In 2011, we conducted the Diabetes MILES
(Management and Impact for Long-term Empowerment
and Success)—Australia study.29 The aim of this national
survey of Australian adults living with type 1 or type 2
diabetes was to assess the psychosocial aspects of living
with diabetes. The 2011 survey was funded primarily by
the National Diabetes Services Scheme (NDSS), an ini-
tiative of the Australian Government administered with
the assistance of Diabetes Australia. The NDSS provides
subsidised products, information and support services
for Australians with diabetes, and funds strategic initia-
tives that align with national priorities. Most Australians
diagnosed with diabetes are registered with the scheme,
and most participants from the ﬁrst Diabetes MILES—
Australia study were recruited from the NDSS registrant
database.
Diabetes MILES—Australia represented a major
achievement in the study of diabetes in Australia, as it
was the ﬁrst time that the psychological health,
behavioural diabetes management, social impacts and
unmet needs of a large and diverse national sample
were assessed, providing a baseline against which the
results of future studies can be compared.
The ﬁndings of the 2011 Diabetes MILES—Australia
study have been disseminated widely in journal articles, at
national and international conferences, and at health
professional training days and community seminars.
Publications have addressed a diverse range of topics
including psychological insulin resistance among adults
with type 2 diabetes;30–32 subjective well-being33 and
suicidal ideation34 among adults with type 1 or type 2
diabetes; measurement of diabetes distress;35 the
relationships between healthcare access and self-
management and self-efﬁcacy,36 economic hardship,37
and rural/regional living;38 and the challenges faced
by speciﬁc groups such as young adults with type 2
diabetes39 and severely obese adults with type 2
diabetes.40–42 Collectively, the ﬁndings from the 2011
Diabetes MILES—Australia survey have provided crucial
evidence to inform policy, practice and service delivery
for adults with type 1 and type 2 diabetes in Australia. For
example, the 2011 Diabetes MILES—Australia survey
indicated that emotional distress is common among
Australian adults with diabetes, and subjective well-being
is lower in this group than in the general Australian
population.33–35 43 In response to this evidence, the
NDSS initiated the Diabetes and Mental Health National
Development Programme, which was led by JS with
contributions from CH, JLB and ADV. This Programme
constituted a multipronged approach to further under-
standing the psychological needs of adults with diabetes,
and developing resources (eg, the Diabetes and
Emotional Health Handbook,44 and related leaﬂets for
people with diabetes) to aid diabetes health professionals
to integrate into routine care psychologically sensitive
practices (eg, being alert to and identifying, assessing
and addressing diabetes distress). Further, using the 2011
survey evidence about the impaired well-being of
Australians with diabetes, CH and JS consulted the
2016–2018 revision of the Royal Australian College of
General Practitioners Guidelines for General Practice
Management of Type 2 Diabetes, which consequently
includes a recommendation to screen adults with type 2
diabetes for diabetes distress and depressive symptoms
annually. Another key ﬁnding from the 2011 survey was
that negative insulin appraisals among adults with type 2
diabetes can persist beyond insulin initiation, and that
these negative appraisals were associated with impaired
emotional well-being.31 This result highlighted the need
for ongoing assessment of attitudes towards insulin, and
holistic, continuing support for this group. In response,
the research team is currently working with diabetes orga-
nisations (eg, Diabetes Victoria) to develop plans for
further support, education and intervention for adults
with type 2 diabetes using insulin.
The Diabetes MILES Study is now an international col-
laborative, with a similar survey having been conducted
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in the Netherlands.45 Diabetes MILES—Youth, a national
survey of Australian adolescents with diabetes (aged 12–
18 years) and their parents, was conducted in 2014.46
While the 2011 Diabetes MILES—Australia study pro-
vided a valuable ‘snapshot’, this cross-sectional survey
does not allow assessment of change over time, or
associations between exposure to a new condition
(eg, initiation of insulin therapy) and key outcomes
(eg, emotional well-being and treatment self-efﬁcacy).
Diabetes treatments, programmes and services are con-
tinually developing and advancing,47 and ongoing survey
research at a national level will enable us to track psy-
chosocial well-being and self-management behaviour in
parallel with these changes. Further, as psychosocial
research in diabetes gains traction and the ﬁeld
expands, new avenues of investigation have been identi-
ﬁed and novel topics of interest have emerged.
Examples include stigmatisation of, and discrimination
against, people with diabetes,5 48 49 memory and cogni-
tion,50 and self-compassion.51 Until now, there is little to
no population-based data on these important topics in
relation to diabetes.
To ﬁll these gaps, we conducted the second Diabetes
MILES—Australia (MILES-2) study. In this paper, we
detail the methods and cohort proﬁles of the MILES-2
survey participants. This study had two elements, each
with different aims:
1. Longitudinal cohort: a follow-up survey of the 2011
Diabetes MILES—Australia participants to allow
assessment of change over time in, and prospective
investigation of, key psychological and behavioural
outcomes. The longitudinal data will enable explor-
ation of key topics, such as:
A. Potential impact of changes in treatment (eg, ini-
tiation of insulin therapy) and/or self-care
regimen (eg, changes in glucose monitoring
behaviours) on diabetes-speciﬁc distress;
B. The psychological (eg, illness beliefs, anxiety,
depression) and behavioural (eg, healthcare
visits, diabetes self-care) antecedents of diabetes
complications (eg, diabetic retinopathy);
C. Prospective predictors of the development of psy-
chological problems (eg, depressive or anxiety
symptoms) or diabetes complications.
2. 2015 new cohort: a cross-sectional survey of a new
national sample of adults with type 1 or type 2 dia-
betes to introduce novel, emerging topics of investiga-
tion. These new cross-sectional data will enable
exploration of novel topics, such as:
A. Perceived and experienced diabetes stigma and
weight stigma, and their associations with key psy-
chological problems (eg, depressive symptoms)
and behavioural issues (eg, medication-taking
and blood glucose monitoring);
B. The relationship between prospective memory
(ie, remembering to perform a planned action)
and diabetes self-care behaviours;
C. The relationship between self-compassion and
the experienced emotional burden of diabetes
(eg, diabetes-speciﬁc distress).
The reasons for the 4-year intervening period between
the ﬁrst and second MILES surveys were both academic
and pragmatic. First, an a priori decision was taken in
2011 to follow-up the initial cohort of participants within
5 years (pending funding, which became available in
early 2015); and 2011 participants who agreed to join
the longitudinal cohort consented expressly to being
contacted within this time frame. Second, as alluded to
above, new priority research areas had emerged in the
intervening time, and any further lag in collecting new
data would have unnecessarily delayed the advancement
of knowledge on important topics. Finally, many of the
core measures administered to participants in the 2011
and 2015 surveys assess individual-level variables (eg,
depressive symptoms) that can reasonably be expected
to change in a period of 4 years.
COHORT DESCRIPTIONS
Study design and setting
The MILES-2 survey (both for the longitudinal cohort
and the 2015 new cohort) was conducted primarily
online, although a hard copy version was made available
for those who requested it (eg, due to not having access
to, or not knowing how to use, the internet). The study
was conducted and is reported according to the
Checklist for Reporting Results of Internet E-Survey
(CHERRIES, see online supplementary appendix 1).52
The survey content and procedure used for the longi-
tudinal and new cohorts were near identical. The
methods described below refer to both cohorts unless
speciﬁed otherwise.
Participant eligibility and recruitment
Eligible participants were adults (aged 18–75 years)
living in Australia who had type 1 or type 2 diabetes,
and were proﬁcient in English for the purposes of
reading and completing the survey (as it was available in
English only). People with other types of diabetes (eg,
gestational, Mature Onset Diabetes of the Young
(MODY), Latent Autoimmune Diabetes in Adults
(LADA)) were not eligible to take part because the
survey content was not tailored to address issues speciﬁc
to these special groups. Similarly, people under the age
of 18 and over the age of 75 years were not eligible for
participation because the survey content and format
were likely to be inappropriate for these groups; and, in
the case of those under 18 years, so as not to duplicate
the efforts of the recent Diabetes MILES Youth survey.46
Longitudinal cohort recruitment
Of the 3833 respondents to the 2011 Diabetes MILES—
Australia survey, 2153 (56%) consented to being invited
to take part in future longitudinal cohort studies and
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provided complete email or postal addresses to facilitate
contact. Invitations were sent by email where possible
(n=1643), with postal invitations sent initially to only 510
participants who did not provide an email address. An
additional 338 invitations were sent by post after email
bounce-backs were received. Overall, 88 participants
were not contactable by email or post (invitation
returned to sender). Thus, 2065 participants of the 2011
survey received an invitation to take part in the MILES-2
survey; a single reminder email/letter was sent 3 weeks
later.
2015 New cohort recruitment
As in the 2011 survey, the NDSS registrant database was
used to contact potential participants. Of the 1.2 million
NDSS registrants,53 ∼47% have indicated consent to be
contacted about research participation opportunities. Of
these, a stratiﬁed random sample of 20 000 registrants
were sent a postal invitation directly by the NDSS (ie,
researchers did not have access to the database), which
directed them to the online survey website and provided
researcher contact details. The sample was stratiﬁed
according to population in each Australian state, and as
follows:
▸ Eight thousand with type 1 diabetes (40% of the total
sample)
▸ Twelve thousand with type 2 diabetes (60% of the
total sample), 6000 of whom registered as using
insulin (50% of the type 2 diabetes sample)
Adults with type 1 diabetes and with type 2 diabetes
using insulin were purposefully over-sampled to ensure
adequate representation of these subsamples. The
sample was not stratiﬁed by gender.
To ensure that the sample was indeed a new cohort of
participants, registrants who were randomly sampled
during recruitment for the 2011 Diabetes MILES—
Australia survey were excluded from the 2015 sampling.
Finally, the study was also advertised nationwide in
diabetes-related media (eg, magazines, e-newsletters,
social media).
Data collection and handling procedure
Potential participants were directed to the study
website54 which presented a plain language description
of the study and an online consent form. Those who
provided informed consent were directed through to
the eligibility screening. Ineligible participants were
screened out automatically and presented with a
message thanking them for their interest and advising
them that they were not eligible to take part. Eligible
participants were directed through to the survey proper.
At the end of the survey, all respondents were invited to
provide their email address to facilitate one or more of
the following: (1) entry into a prize draw (chance to win
one of three iPad minis), (2) to receive a free electronic
copy of the study report, (3) to receive notiﬁcations
about future research opportunities, (4) to withdraw
data at a later date. Provision of an email address was
voluntary, and participants could select to which of the
four options they consented.
The MILES-2 survey was hosted by Qualtrics, a secure
online survey platform. The survey was open for partici-
pation for 7 weeks (23 March—11 May 2015). As partici-
pants progressed through the survey, their data were
saved automatically by Qualtrics.
All online survey responses (complete and incom-
plete) were logged by the Qualtrics survey platform and
downloaded at survey close into data ﬁles for analysis in
Statistical Package for the Social Sciences (SPSS) (IBM
SPSS Statistics for Windows, V.22.0. Armonk, New York,
USA: IBM Corp). Hard copy survey responses were
entered manually into the SPSS data ﬁle by one
researcher, and checked for accuracy by a second
researcher. Contact details were extracted from the main
data ﬁle and stored separately in a password-protected
folder. Longitudinal cohort participants’ 2015 data were
matched with their existing 2011 data using the unique
log-in code provided, and by validating the match
against diabetes type, age and gender.
A total of 2651 survey responses were recorded by
Qualtrics. However, 148 duplicate cases were identiﬁed
in the data ﬁle (using a combination of IP address and
demographic/clinical data such as age, gender, postcode
and diabetes type) and deleted. The main reasons for
duplicate cases were:
A. Participants who were screened out at the eligibility
assessment phase restarted the survey to answer the
screening questions in a different way (eg, changing
diabetes type response from ‘MODY’ to ‘type 2 dia-
betes’), allowing them to unlock the full survey. In
these instances, their second attempt was deleted
and their data were not included in any analysis due
to ineligibility.
B. Participants who lost their internet connection or
their responses failed to save, and they restarted the
survey in order to complete it. In these instances, the
most complete entry was retained and the other
deleted. If there was no difference in the amount of
data available in each case, the ﬁrst entry was retained.
Response rate
A total of 2503 unique consenting responses (27 hard
copy completions) to the MILES-2 survey were identiﬁed,
including 2015 new cohort (n=1970) and longitudinal
cohort (n=533) respondents. The response rates for
these separate subsamples are discussed separately below.
The 2015 new cohort participants who passed the eli-
gibility screening (n=1829, 93%) had the opportunity to
indicate how they heard about the survey. Seventy-nine
per cent (n=1453) of this subsample indicated that they
received a letter from the NDSS inviting them to take
part, indicating a response rate of 7% of the 20 000 NDSS
registrants who received an invitation. Extrapolating this
rate to also include those screened out due to ineligibility,
the estimated total response rate to the NDSS mail-out
is 8%.
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Of the 2065 participants of the original 2011 survey,
who indicated willingness to be contacted about similar
studies in the future, 533 (26%) participated, and are
referred to hereafter as the longitudinal cohort. Reasons
for non-participation are not known.
Final eligible samples and their characteristics
Of the 2503 unique respondents, 161 were screened out
due to ineligibility. The ﬁnal cross-sectional sample
included N=2342 eligible participants, comprising
n=1838 2015 new cohort participants and n=504 longitu-
dinal cohort participants. Full sample characteristics are
presented in table 1.
In the ﬁnal sample, 46% had type 1 diabetes and 54%
had type 2 diabetes. Overall, men and women were
represented equally (50% vs 50%). Unsurprisingly, parti-
cipants with type 2 diabetes were substantially older than
participants with type 1 diabetes (mean difference:
17 years), but reported shorter diabetes duration (mean
difference: 8 years). Among those with type 1 diabetes,
35% were managing their diabetes with an insulin
pump. Among those with type 2 diabetes, 42% were
using insulin. Most respondents spoke English as their
main language (97%), were married or in a de facto
relationship (68%), had vocational or university qualiﬁ-
cations (66%), lived in metropolitan areas (61%), were
in paid employment (54%) and had an annual house-
hold income of more than $A40 000 per annum (54%).
Tight CIs of 2.02 were evident (calculated using a
worst-case scenario proportion of 50%, a 95% conﬁ-
dence level and sample size of 2342), providing evidence
of sample adequacy.
Table 2 compares the sample characteristics of the lon-
gitudinal and 2015 new cohorts. With few exceptions, the
longitudinal and new cohorts were equivalent on key
sociodemographic and clinical characteristics, indicating
that the cohorts may be pooled for future analyses. On
average, participants with type 1 diabetes in the longitu-
dinal cohort were older and had a longer diabetes dur-
ation than those in the new cohort, but while the
difference was signiﬁcant, it was not notable (<5-year
mean difference in both instances). Respondents with
type 1 diabetes in the longitudinal cohort were more
likely to be using an insulin pump than those in the new
cohort. Regardless of diabetes type, compared with
respondents in the new cohort, those in the longitudinal
cohort were more likely to have a university education,
less likely to have no qualiﬁcations, and more likely to
reside in the state of Victoria.
Depth and breadth of available data
Consistent with the aims of the Diabetes MILES Study
initiative, the data available primarily relate to the psy-
chological (eg, emotional well-being), behavioural (eg,
self-management) and social (eg, diabetes stigma)
aspects of living with diabetes. These data make possible
the assessment of prevalence, relationships between key
variables and (in the longitudinal cohort), change over
time and associations between exposure to a new condi-
tion and key outcomes.
The survey included validated scales, study-speciﬁc
individual items and newly developed measures (for val-
idation). For ‘core’ constructs (eg, general and diabetes-
speciﬁc emotional well-being), the measures used in
2011 were included in the 2015 survey. This was import-
ant in order to generate a longitudinal data set for asses-
sing within-group change over time, as well as to enable
comparison on key issues of the full 2011 and 2015 study
samples as representative ‘snapshots’ of the Australian
population of adults with diabetes.
While the 2011 and 2015 surveys had similar content,
they were not identical. Some measures (eg, Resources
and Support for diabetes Self-Management question-
naire) were not repeated in 2015 because ongoing data
collection on the topic was not considered a key priority.
Some measures were replaced with another measure of
the same construct (eg, the Diabetes Self-Care Inventory
—Revised was replaced with the Summary of Diabetes
Self-Care Activities55). Some measures were replaced
with a shorter version to reduce respondent burden (eg,
the Quality of Life Questionnaire was replaced with the
DAWN Impact of Diabetes Proﬁle5). Finally, some mea-
sures were replaced with measures tailored to diabetes
type and/or treatment (eg, the Diabetes Empowerment
Scale Short-Form56 was replaced with the Conﬁdence in
Diabetes Self-care scale, with insulin-using57 and non-
insulin using58 versions.
In the original (2011) Diabetes MILES study, two alter-
nate survey versions (A and B) were used. To ensure
that all longitudinal cohort participants had complete
data sets for key variables (eg, diabetes-speciﬁc distress),
their 2015 survey content was tailored automatically
(based on the unique code they entered) to match the
survey version they completed in 2011. However, this
automatic tailoring was not possible for those complet-
ing the hard copy surveys (n=27) and thus they were
treated as new cohort participants.
Survey content was grouped by theme into eight sec-
tions: (1) Demographics, (2) My general well-being, (3)
My feelings about diabetes, (4) My general health, (5)
Support from health professionals, family and friends,
(6) My diabetes, (7) My blood glucose levels, (8) My
thoughts and beliefs. It was also tailored to diabetes type
and treatment (based on information provided in the
Demographics section of the survey) and, as such, not all
measures were presented to every participant. Table 3
summarises the topics/constructs, variables and measures
used in the 2015 MILES-2 survey (for both the new and
longitudinal cohorts separately) and also indicates which
of the same content was included in the 2011 survey.
FINDINGS TO DATE
Sample stratification
The success of the stratiﬁed sampling approach was
assessed by comparing the subsample of new cohort
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Table 1 Sample characteristics for the 2015 Diabetes MILES—Australia survey, by diabetes type*
Type 1 diabetes
n=1078 (46)
Type 2 diabetes
n=1264 (54)
Total sample
N=2342 (100)
Gender—female 639 (59) 539 (43) 1178 (50)
Age—years 44±15 (18–75) 61±9 (22–75) 53±15 (18–75)
Diabetes duration—years 19±14 (0–68) 11±7 (0–44) 15±12 (0–68)
Primary diabetes management
Insulin pump therapy 380 (35) 2 (0.2) 382 (16)
Insulin injections 698 (65) 529 (42) 1227 (52)
Non-insulin injectables − 47 (4) 47 (2)
Blood glucose-lowering tablets − 510 (40) 510 (22)
Diet and/or exercise alone − 176 (14) 176 (8)
Aboriginal or Torres Strait Islander 14 (1) 22 (2) 36 (2)
Main language spoken at home—English 1054 (98) 1214 (96) 2268 (97)
Country of birth—Australia 831 (77) 889 (70) 1720 (73)
Relationship status
Single 241 (22) 111 (9) 352 (15)
In a steady relationship 52 (5) 21 (2) 73 (3)
Married or De Facto 706 (66) 891 (71) 1597 (68)
Separated 18 (2) 36 (3) 54 (2)
Divorced 48 (4) 130 (10) 178 (8)
Widowed 8 (1) 71 (6) 79 (3)
Education
No qualifications 30 (3) 125 (10) 155 (7)
School/intermediate certificate 105 (10) 205 (16) 310 (13)
High school/leaving certificate 181 (17) 140 (11) 321 (14)
Trade training or diploma(s) 252 (23) 382 (30) 634 (27)
University undergraduate degree 269 (25) 223 (18) 492 (21)
Higher university degree 236 (22) 185 (15) 421 (18)
(Un)Employment details
Paid employment 770 (72) 477 (38) 1247 (54)
Retired 146 (14) 579 (46) 725 (31)
Full-time student 26 (2) 8 (1) 34 (2)
Unpaid household duties 40 (4) 49 (4) 69 (3)
Unemployed 86 (8) 146 (12) 232 (10)
Other 8 (1) 4 (0.3) 12 (1)
Annual household income ($A)
≤20 000 130 (12) 225 (18) 355 (15)
20 001–40 000 123 (12) 281 (23) 404 (17)
40 001–60 000 135 (13) 199 (16) 334 (14)
60 001–100 000 240 (23) 175 (14) 415 (18)
100 001–150 000 158 (15) 113 (9) 271 (12)
>150 000 123 (12) 75 (6) 198 (9)
Do not know/prefer not to say 155 (15) 177 (14) 332 (14)
State
Australian Capital Territory 54 (5) 132 (10) 186 (8)
New South Wales 345 (32) 258 (20) 603 (26)
Northern Territory 9 (0.8) 41 (3) 50 (2)
Queensland 140 (13) 143 (11) 283 (12)
South Australia 86 (8) 120 (10) 206 (9)
Tasmania 50 (5) 120 (10) 170 (7)
Victoria 281 (26) 297(24) 578 (25)
Western Australia 113 (10) 151 (12) 264 (11)
Geographical location
Metropolitan 483 (63) 750 (60) 1433 (61)
Regional 272 (25) 303 (24) 575 (25)
Rural 122 (11) 206 (16) 328 (14)
Data are n (%) or mean±SD (range).
*Total N reported is not always consistent with total sample size due to missing data for some variables. Percentages do not always sum to
100 due to rounding.
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Table 2 Sample characteristics by cohort*
Longitudinal Cohort 2015 new Cohort Significance
Total eligible sample 504 (22)† 1838 (79)
Gender—female 261 (52) 917 (50) NS
Diabetes type NS
Type 1 diabetes 236 (47) 842 (46)
Type 2 diabetes 268 (53) 996 (54)
Age—years
Type 1 diabetes 47±14 43±16 <0.001
Type 2 diabetes 62±8 61±10 NS
Diabetes duration—years
Type 1 diabetes 22±14 18±14 <0.001
Type 2 diabetes 12±7 11±8 NS
Primary treatment for type 1 diabetes <0.001
Insulin pump therapy 106 (45) 274 (33)
Insulin injections 130 (55) 568 (67)
Primary treatment for type 2 diabetes NS
Insulin pump therapy 0 (0) 2 (0.2)
Insulin injections 95 (35) 434 (44)
Non-insulin injectables 11 (4) 36 (4)
Blood glucose-lowering tablets 119 (44) 391 (39)
Diet and/or exercise alone 43 (16) 133 (13)
Aboriginal or Torres Strait Islander origin 5 (1) 31 (2) NS
Main language spoken at home—English 494 (98) 1774 (97) NS
Country of birth—Australia 387 (77) 1333 (73) NS
Relationship status NS
Single 64 (13) 288 (16)
In a steady relationship 12 (2) 61 (3)
Married or De Facto 356 (71) 1241 (68)
Separated 12 (2) 42 (2)
Divorced 44 (9) 134 (7)
Widowed 15 (3) 64 (3)
Education <0.001
No qualifications 15 (3) 140 (8)
School/intermediate certificate 68 (14) 242 (13)
High school/leaving certificate 58 (12) 263 (14)
Trade training or diploma(s) 132 (26) 502 (28)
University undergraduate degree 123 (25) 369 (20)
Higher university degree 106 (21) 315 (17)
(Un)Employment details NS
Paid employment 280 (56) 967 (53)
Retired 155 (31) 570 (31)
Full-time student 6 (1) 28 (2)
Unpaid household duties 26 (5) 63 (3)
Unemployed 35 (7) 197 (11)
Other 2 (0.4) 10 (1)
Annual household income ($A) NS
≤20 000 67 (13) 288 (16)
20 001–40 000 79 (16) 325 (18)
40 001–60 000 80 (16) 254 (14)
60 001–100 000 94 (19) 321 (18)
100 001–150 000 61 (12) 210 (12)
>150 000 57 (11) 141 (8)
Do not know/prefer not to say 65 (13) 267 (15)
State <0.001
Australian Capital Territory 17 (3) 169 (9)
New South Wales 105 (21) 498 (27)
Northern Territory 1 (0.2) 49 (3)
Queensland 81 (16) 202 (11)
South Australia 25 (5) 181 (10)
Continued
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respondents who indicated that they received an invita-
tion direct from the NDSS against the planned stratiﬁca-
tion (described in Methods). Respondents with type 1
diabetes were slightly over-represented in the new
cohort (45%) relative to the planned stratiﬁcation (40%
type 1 diabetes, 60% type 2 diabetes). Relative to the
planned stratiﬁcation for state (designed to reﬂect the
proportion of NDSS registrants per state), there was evi-
dence of over-sampling of participants in the Australian
Capital Territory (3% invited vs 11% response), New
South Wales (21% vs 26%), the Northern Territory (1%
vs 3%) and Tasmania (3% vs 10%). Under-sampling of
participants was evident in Queensland (19% invited vs
12% response), South Australia (16% vs 11%), Victoria
(20% vs 15%) and Western Australia (17% vs 12%).
Respondents with insulin-treated type 2 diabetes were
under-represented in the new cohort relative to the
stratiﬁed sampling (50% invited vs 44% response).
Longitudinal cohort data matching
Of the 504 eligible participants who completed the lon-
gitudinal cohort survey, 459 (91%) were matched with
their original 2011 data. The representativeness of the
longitudinal data set compared to the original 2011
sample can be assessed by comparing the sample
characteristics of those who took part in 2011 and 2015
with those who took part in 2011 only. As shown in table
4, participants who completed both the 2011 and 2015
surveys were slightly more likely than those completing
the 2011 survey only to have type 1 diabetes, report a
higher education and annual income, and live in metro-
politan regions of Australia. For those with type 1 dia-
betes, those who participated in the 2011 and 2015
surveys had a longer mean diabetes duration relative to
those who took part in 2011 only. Among those with
type 2 diabetes, the reverse was true: participants of both
the 2011 and 2015 surveys had a shorter mean diabetes
duration compared to those who took part in 2011 only.
Qualitative findings
The qualitative data provided by participants in the free-
text boxes indicated that, in general, the survey was
highly acceptable to participants. While some partici-
pants felt the survey was too long, others were apprecia-
tive of the comprehensive and thoughtful nature of this
research. For many, it promoted further learning about
diabetes, and a chance to reﬂect on their attitudes to
living with diabetes:
Doing this survey makes me realise that I could access
support networks/forums/healthcare practitioners more
than I actually do (woman, 31 years, type 1 diabetes)
Some participants perceived that psychological support
doesn’t exist (woman, 25 years, type 1 diabetes) for their
diabetes-related concerns, and therefore were pleased
that this work was being conducted:
I would like to say thank you for this survey, as it‘s good
to know that there are people concerned with diabetes
and the issues we may have (man, 67 years, type 2
diabetes)
STRENGTHS AND LIMITATIONS
Strengths
Key strengths of MILES-2 are the breadth and depth of
quantitative data and the large population-based sample
size that will afford the necessary statistical power to
investigate subgroups and conduct multivariate analyses.
Our CI calculations conﬁrm that this sample size is
adequate to facilitate relatively accurate estimations of
population-level statistics. While clinical and biomedical
research abounds in the ﬁeld of diabetes, there is a
pressing need for an increased research focus on the
psychosocial aspects of the condition.27 MILES-2 contri-
butes to this gap in our knowledge by providing a rich
data set that combines cross-sectional and longitudinal
assessment of key topics such as emotional well-being,
self-management and healthcare access, as well as intro-
ducing novel topics of investigation such as social stigma,
cognition and memory, and self-compassion. The quali-
tative feedback from participants indicated that the
topics included in the survey were relevant to them, and
the survey was generally very well received.
Table 2 Continued
Longitudinal Cohort 2015 new Cohort Significance
Tasmania 12 (2) 158 (9)
Victoria 215 (43) 363 (20)
Western Australia 47 (9) 217 (12)
Geographical location NS
Metropolitan 312 (63) 1121 (61)
Regional 127 (25) 448 (24)
Rural 63 (13) 265 (14)
Data are n (%) or mean±SD (range).
*Table refers only to eligible participants. Total N reported is not always consistent with total sample size due to missing data on some items.
Percentages do not always sum to 100 due to rounding.
†Of the 504 longitudinal cohort participants, 459 could be matched with 2011 data.
NS, not significant.
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Table 3 Survey content for the 2015 Diabetes MILES–Australia survey
Concept/topic Measure or variable
2015 new
cohort
Longitudinal
cohort
2011
survey
Demographics
Eligibility screen Diabetes type, age, live in Australia
✓ ✓ ✓
Demographic and
socioeconomic details
Gender, state, postcode, country of birth, language,
marital status, living situation, income, employment,
education
Diabetes details Diabetes duration, diabetes treatment
Other Diabetes organisation membership, how they heard
about survey
My general well-being
General emotional
well-being
World Health Organisation Well-being Index
(WHO-5)59
✓ ✓ ✓General life satisfaction (single item)60
Depressive symptoms Patient Health Questionnaire (PHQ-8)61
Anxiety symptoms Generalised Anxiety Disorder scale (GAD-7)62
My feelings about diabetes
Diabetes-specific distress Problem Areas In Diabetes Scale (PAID)63 ✓ ✓* ✓*
Diabetes Distress Scale (DDS)64 ✓† ✓†
Type 1 Diabetes Distress Scale (T1-DDS)65 ✓†‡
Diabetes-related and
generic stigma
Type 1 and Type 2 Diabetes Stigma Assessment Scales
(DSAS-166; DSAS-2 67)
✓ ✓*
Stigma Scale for Chronic Illnesses-8 item version
(SSCI-8)68
✓ ✓*
6 study-specific items about portrayal of diabetes in
the media
✓ ✓
Quality of life DAWN Impact of Diabetes Profile (DIDP)5 ✓ ✓
Illness centrality Centrality Scale69 ✓ ✓
My general health
Health background Physical and mental health comorbidities and
complications, height and weight, smoking status,
health insurance and pension
✓ ✓ ✓
Weight stigma Weight Self-Stigma Questionnaire (WSSQ)70 ✓ ✓
Memory Prospective and Retrospective Memory Questionnaire
(PRMQ)71
✓ ✓
Support from health professionals, family and friends
Healthcare Access to providers in past 12 months, main provider,
group structured education
✓ ✓ ✓
Social support Diabetes Support Scale (DSS)72 ✓ ✓
Social Support subscale of Diabetes Care Profile (DCP)73 ✓ ✓
Peer support Study-specific items ✓ ✓
My diabetes
Self-care Diet and physical activity subscales of the Summary of
Diabetes Self-Care Activities (SDSCA)55
✓ ✓
Study-specific items: dietary behaviours ✓ ✓
Study-specific items: physical activity behaviours ✓ ✓
Study-specific items: blood glucose monitoring ✓ ✓
Modified importance and burden items (for diet,
physical activity, blood glucose monitoring) from the
Summary of Diabetes Self-Care Inventory-Revised
(unpublished)
✓ ✓
Diabetes treatment Study-specific items assessing frequency/time of day
for injections/bolusing, frequency of forgetting and
skipping injections/bolus/medication dose, reasons for
forgetting/skipping
✓ ✓
Continued
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The survey was conducted primarily online, with only
27 of the 2342 respondents (1%) asking to complete a
hard copy version. The online survey methods were suc-
cessful in generating a sample with gender balance, a
wide age range, diverse socioeconomic backgrounds and
a representative mix of people living in metropolitan,
regional and rural areas in all states and territories of
Australia. The online survey was a successful and eco-
nomical approach to surveying a wide range of
Australian adults with diabetes, all within a relatively
short time period (7 weeks).
The signiﬁcance of the emerging longitudinal data set
is particularly noteworthy. For the ﬁrst time, it will be
possible to explore predictors and consequences of psy-
chological distress and suboptimal behavioural diabetes
management in a non-clinical, population-based sample.
It represents the ﬁrst attempt to track the natural trajec-
tory of emotional problems in people with diabetes (eg,
diabetes distress) and to investigate any social, economic
and/or demographic factors that may contribute to vari-
ation in psychological experiences. This in turn will
enable better tailoring of interventions to meet those
with the greatest need. It is our intention to conduct
further surveys in the future to continue to follow all
respondents who have indicated their willingness to con-
tinue their participation. This will enable us to build on
the existing longitudinal data set using a third wave of
data collection, and to increase the sample size and
breadth of survey topics available in the longitudinal
cohort.
Limitations
Response rates
The response rates for both the longitudinal and the
new cohorts in the MILES-2 survey were low; the longitu-
dinal cohort had a markedly better response rate (26%)
than the 2015 new cohort (8%). It is possible that
respondents who agreed to take part in future surveys in
2011 had a higher level of commitment to and interest
in the Diabetes MILES Study due to their previous
participation.
In the longitudinal cohort, substantial attrition was
evident between the 2011 and 2015 surveys, and the
response rate is notably lower than other
health-related longitudinal Australian surveys.82 83
However, these other initiatives were very well
resourced, enabling many repeat attempts at contact
using various methods. For MILES-2, only two contacts
were possible (invitation plus one reminder). Further,
MILES-2 focused speciﬁcally on adults with type 1 or
type 2 diabetes aged 18–75 years, whereas, in contrast,
the other initiatives sampled the general population
Table 3 Continued
Concept/topic Measure or variable
2015 new
cohort
Longitudinal
cohort
2011
survey
HbA1c Study-specific items ✓ ✓ ✓
App use for
self-management support
Study-specific items ✓ ✓
Diabetes-specific
self-efficacy
Confidence In Diabetes Self-Care (CIDS)
(insulin-using 57 and non-insulin-using versions 58)
✓ ✓
Psychological insulin
resistance
Insulin Treatment Appraisal Scale (ITAS)74 ✓§ ✓§ ✓§
‘Willingness to begin insulin’ single item75 ✓§ ✓§
My blood glucose levels
Hyperglycaemia Two items adapted from the Hyperglycaemia Avoidance
Scale (HAS)76
✓‡ ✓‡
Hypoglycaemia Study-specific items (some based on the
Hypoglycaemia Awareness Questionnaire 77) to
assess frequency, hospitalisation, insulin adjustment in
response to hypoglycaemia, impaired awareness of
hypoglycaemia
✓ ✓ ✓
Edinburgh Hypoglycaemia Survey (EHS)78 ✓ ✓
Gold Score79 ✓ ✓ ✓
My thoughts and beliefs
Self-esteem Rosenberg Self-Esteem Scale (RSE)80 ✓ ✓
Self-compassion Self-Compassion Scale Short Form (SCS-SF)81 ✓ ✓
Other Free-text box inviting participants to make any other
comments
✓ ✓ ✓
*Participants who completed survey B version in 2011 only.
†Participants who completed survey A version in 2011 only.
‡Participants with type 1 diabetes only.
§Participants with type 2 diabetes only.
HbA1c, glycated haemoglobin.
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and did not focus on a particular condition. It has
been noted that the population being sampled is the
most important determining factor for survey response
rates,84 and thus comparison of the MILES-2 response
rate with other Australian general population surveys is
not necessarily appropriate. People with diabetes are
more likely than the general population to have
serious physical and mental health comorbid-
ities,12 13 85 86 impaired general well-being,33 and
those with type 2 diabetes are more likely to be
Table 4 Baseline characteristics of longitudinal survey completers (2015 and 2011) versus non-completers (2011 only)*
2011 only
(cross-sectional) cohort
2011 and 2015
(longitudinal) cohort Significance
TOTAL 2879 (86) 459 (14)
Gender—female 1538 (54) 240 (53) NS
Diabetes type 0.002
Type 1 diabetes 1157 (40) 219 (48)
Type 2 diabetes 1722 (60) 240 (52)
Age—years
Type 1 diabetes 42±14 43±13 NS
Type 2 diabetes 59±9 57±8 0.016
Diabetes duration—years
Type 1 diabetes 15±13 18±14 0.001
Type 2 diabetes 9±7 8±6 0.030
Primary treatment for type 1 diabetes <0.001
Insulin pump therapy 246 (21) 79 (36)
Insulin injections 902 (79) 140 (64)
Primary treatment for type 2 diabetes 0.002
Insulin pump therapy 8 (0) 0 (0)
Insulin injections 642 (39) 72 (30)
Non-insulin injectables 15 (1) 7 (3)
Blood glucose-lowering tablets 767 (45) 109 (45)
Diet and/or exercise alone 266 (16) 52 (22)
Aboriginal or Torres Strait Islander origin 47 (2) 2 (0) 0.037
Main language spoken at home—English 2759 (97) 446 (98) NS
Country of birth—Australia 2119 (74) 354 (77) NS
Relationship status NS
Single 391 (14) 59 (139)
In a steady relationship 105 (4) 20 (4)
Married or De Facto 1945 (69) 325 (71)
Separated 77 (3) 6 (1)
Divorced 216 (8) 39 (9)
Widowed 89 (3) 7 (2)
Education <0.001
No qualifications 254 (9) 12 (3)
School/intermediate certificate 308 (11) 34 (8)
High school/leaving certificate 552 (20) 79 (18)
Trade training/certificate/diploma 848 (31) 135 (30)
University undergraduate degree 474 (18) 108 (24)
Higher university degree 271 (10) 81 (18)
In paid employment 1654 (57) 310 (68) <0.001
Annual household income ($A) <0.001
≤20 000 539 (20) 57 (13)
20 001–40 000 500 (19) 59 (13)
40 001–60 000 502 (19) 79 (18)
60 001–100 000 579 (21) 120 (27)
100 001–150 000 346 (13) 81 (18)
>150 000 228 (8) 52 (12)
Geographical location <0.001
Metropolitan 1425 (51) 275 (61)
Regional 808 (29) 116 (26)
Rural 587 (21) 63 (14)
Data are n (%) or mean±SD (range).
*Data from 2011 Diabetes MILES—Australia.
NS, not significant.
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socioeconomically disadvantaged,87 making non-
response and problematic attrition more likely.88 89
Another possible explanation for the relatively high
rate of attrition between the 2011 and 2015 surveys is
the different methods of recruitment and data collec-
tion. In 2011, participants received a hard copy survey;
online survey completion was possible but 70% of 2011
survey respondents completed the hard copy version. In
contrast, the 2015 survey was online by default, and
respondents needed to request a hard copy. This may
have created too many barriers to participation for
some, leading to non-response.
The response rate of the 2015 new cohort is low at
8%, and considerably lower than the 18% observed in
the 2011 survey.29 However, a number of factors may
explain this. First, as noted above, the default online
data collection may have been a barrier to participation.
Second, the survey took place at a time when NDSS
registrants were being contacted frequently for research
purposes, which was not the case in 2011. On the advice
of the NDSS, the survey launch date was pushed back
from November 2014 to March 2015 in an attempt to
avoid survey fatigue. However, the low response rate sug-
gests that this delay was insufﬁcient and that NDSS regis-
trants may have been burdened by too many research
participation requests. Finally, online surveys are now
proliﬁc, and decreasing response rates have been noted
elsewhere.84 Thus, the low response rate observed in the
2015 new cohort of the MILES-2 survey may be reﬂective
of a broader trend, compounded by the challenges
faced by this population as already described.
In spite of the low response rates, as noted above, the
sample sizes obtained are more than adequate to facili-
tate inferential data analyses and to draw conclusions
about the unmet needs of Australian adults with type 1
and type 2 diabetes.
Stratification of the new cohort sample
The sampling for the new cohort was stratiﬁed by dia-
betes type, insulin use (type 2 diabetes only) and
Australian state of residence. Respondents with type 1
diabetes were slightly over-represented in our sample
(45%) relative to the stratiﬁcation (40%). This may
reﬂect a generally higher level of engagement in
diabetes-related activities and advocacy in this group
relative to those with type 2 diabetes.
Among respondents with type 2 diabetes, 44% were
using insulin, which is almost double the proportion
observed on the NDSS database (24%), but less than
anticipated given the purposeful sampling stratiﬁcation
(50%). On the basis of our previous research, Australian
adults with type 2 diabetes who use insulin (compared
with those not using insulin) have a longer diabetes dur-
ation,90 are more likely to have at least one diabetes-
related complication,31 32 and are more likely to have
depressive and anxiety symptoms.43 These factors may
make them less likely to engage in research initiatives.88 89
Sample representativeness
The NDSS is considered to be one of the best national
sources of data about Australians with diabetes,91 and
thus the representativeness of our study sample can best
be determined by comparing our sample characteristics
with the NDSS registrant database characteristics.
Notwithstanding the purposeful stratiﬁcation and over-
sampling of adults with type 1 diabetes and those with
insulin-treated type 2 diabetes, the gender balance was
broadly representative of people registered on the NDSS
database.90 Overall, men and women were represented
equally in the sample (50% men; 50% women) and the
proportions in our sample approximate the NDSS regis-
ter (52% men vs 48% women).
Among those with type 1 diabetes, 35% were using an
insulin pump to manage their diabetes. Since only 10%
of adults with type 1 diabetes registered with the NDSS
use an insulin pump,92 it appears that this group is over-
represented in our sample. While insulin pump users
were intentionally over-sampled in the 2011 survey, this
was not the case for the 2015 new cohort, and yet they
were over-represented in the sample anyway. The over-
representation of pump users is consistent with research
participation patterns observed in similar studies.44 45
Pump users may be more engaged in research because
they perceive themselves to beneﬁt from advances in
knowledge, or it may be reﬂective of the fact that pump
users tend to be more highly educated and from higher
socioeconomic backgrounds relative to non-pump users.92
Compared with the Australian general population, our
sample was more likely to speak English as their main lan-
guage,93 to be married or in a de facto relationship,94 to
be in paid employment95 and have post-high school quali-
ﬁcations.96 This indicates that those who took part are a
relatively privileged sample with signiﬁcant social
resources who are likely to have better health literacy and
access to health services than Australians with diabetes
generally. Self-selection bias is commonly observed in web-
based studies,97 98 and may result in the under-estimation
of social and emotional problems, and problems of
healthcare access. In the context of the MILES-2 study,
this bias must be acknowledged as a considerable limita-
tion that may threaten the generalisability of the data to
the broader Australian population of adults with diabetes.
Weighting of cases may be adopted for future analyses,
depending on the subsample and outcome variables
being used. Since a key focus of future inferential analyses
of the MILES-2 data will be the relationships between vari-
ables, the self-selection bias is likely to have minimal
impact on this if cases are weighted accordingly. For
future MILES studies, consideration will be given to strat-
egies that will address the under-sampling of participants
from less advantaged backgrounds such as community
outreach through health professionals and diabetes
clinics, collaborating with researchers with expertise in
working with Aboriginal and Torres Strait Islander com-
munities and stronger promotion of the availability of
hard copy versions of the survey.
12 Browne JL, et al. BMJ Open 2017;7:e012926. doi:10.1136/bmjopen-2016-012926
Open Access
FUTURE DIRECTIONS AND COLLABORATIONS
Subject to funding availability, we plan ongoing
follow-up (approximately every 4 years) of the longitu-
dinal cohort and we expect to be able to grow both the
cohort and the depth and breadth of data available by
also conducting follow-up MILES surveys with the 2015
new cohort. To maintain participant engagement and
therefore aid retention, we are currently writing a report
that summarises top-level ﬁndings of the study for a lay
audience. All MILES-2 participants were given the
opportunity to opt to receive a free electronic copy of
the report when it becomes available.
One key direction for future data analysis and publica-
tion is examination of within-participant changes
between 2011 and 2015 on variables such as depressive
and anxiety symptoms, diabetes distress and insulin
appraisals. Additional priority avenues of enquiry will
include identifying the psychological and behavioural
correlates of diabetes distress, hypoglycaemia avoidance
and depressive symptoms to inform intervention devel-
opment, exploring associations with diabetes stigma and
psychological and behavioural outcomes, characterising
the use of technologies (eg, smartphone apps) to aid
self-management and psychometric analysis of scales
that have not previously been used in an Australian
context (eg, DIDP). Findings from MILES-2 will be dis-
seminated through academic publications, conference
presentations, health professional training and commu-
nity symposia over several years.
We encourage collaborations from researchers with
relevant expertise in the ﬁeld. Researchers may gain
access to the second Diabetes MILES—Australia survey
data set on submission of a proposal detailing the topics
of interest, key research questions and hypotheses.
Proposals will be evaluated by the Diabetes MILES Study
research team on the basis of feasibility, relevance,
novelty and expertise of the researchers. Enquires
should be directed to Browne JL (ﬁrst author).
CONCLUSIONS
The second Diabetes MILES—Australia study builds on
the previous Diabetes MILES Study initiatives to deliver
Australia’s ﬁrst large-scale longitudinal assessment of the
psychosocial aspects of type 1 and type 2 diabetes, and
to introduce novel topics of investigation at a popula-
tion level. The depth and breadth of the data available
in this large sample will raise further awareness of the
psychosocial impact of living with type 1 and type 2
diabetes, will highlight unmet needs and priority
areas for future investigation and, crucially, will inform
policy, programme and intervention development and
evaluation.
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